News

CDMO will be able to produce rAAV commercial grade product

Provides clientele with an augmented drug development solution

Provider’s regulatory affairs, pharmacovigilance services expected to help increase ABC’s portfolio

Semiannual update includes better revenue forecasting and state reporting

Collaboration aims to decrease environmental burden in the space

Lotte Biologics will assume facility ownership, as CDMO joins pharma space with the acquisition

The latest people news happenings over the past month

With the new additions, CDMO expands its analytical testing and development services

Confirms company’s commitment to ESG practices

Acquisition of Evolution Road expands company’s omnichannel know-how

Purchase strengthens Amgen’s therapeutics portfolio

Featuring manufacturing technology, the new facility supports medicines supply chain resilience

Will grow rental program that features environmentally friendly packaging

Big Pharma to collaborate with researchers from A*STAR, along with Singapore universities

Confirms cold chain company’s sustainability commitment

Will further boost CDMO’s injectable drug product platform

Biotech company’s AI/machine learning-enabled platform to design candidates for up to three drug discovery programs

The latest people news happenings over the past month

UAE-based carrier earns recertification based on its compliance to pharma regulations

Site promotes environmental sustainability

Report shows US healthcare professional access approaching 80% in ‘key specialties’

Can help facilitate digital identification of medications

Drug safety analysis to be conducted at Rockland, MD facility

With purchase, UPS Healthcare can grow coverage in Europe, LATAM

Agreement revolves around sustainability, but also features implementation of new bioprocess development methods

Plant will be CDMO’s first standalone GMP and vaccine development manufacturing site in the country

Former Novartis plant will become mRNA manufacturing facility, the first in Singapore

Alliance revolves around interoperability of pharma products as they move through the supply chain